Aerobic granular sludge systems for treating hypersaline pharmaceutical wastewater: Start-up, long-term performances and metabolic function.
The complex organics, residue pharmaceuticals and high salinity in pharmaceutical wastewater pose great challenges to biological wastewater treatment. In this study, granular sludge process was used for treating pharmaceutical wastewater because of its high pollutant removal efficiency. The results suggested that granules could not form within 90-d cultivation when directly fed with target hypersaline pharmaceutical wastewater (RP) due to suppression of EPS secretion by high concentration of inhibitory organics, while granules were successfully developed with hypersaline synthetic wastewater (RS) and diluted pharmaceutical wastewater (RD), respectively. Further comparison of pollutant removal performance from target pharmaceutical wastewater showed that simultaneous removal of organics (effluent bCOD<1 mg L-1) and nitrogen (average TN removal efficiency of 70.3%) could be achieved in RD. Nevertheless, long acclimation period (i.e., 20 d) was needed for granules when carbon source was shifted from simple sodium acetate to complex organic pollutants in pharmaceutical wastewater, with nitrite significantly accumulated in RS. Analysis of microbial community and nitrogen metabolism pathway indicated the higher abundance of nitrite oxidoreductase than that in the RS to alleviate nitrite accumulation in the RD, and functional strains such as Paracoccus and Mycobacterium played critical roles for high efficiency of organic degradation, nitrification and denitrification.
['Jiang|Yu|Y|', 'Shi|Xueqing|X|', 'Ng|How Yong|HY|']
D000332:Aerobiosis D019149:Bioreactors D058440:Denitrification D058465:Nitrification D009584:Nitrogen D004364:Pharmaceutical Preparations D012722:Sewage D014865:Waste Disposal, Fluid D062065:Waste Water
Aerobic granular sludge Pharmaceutical wastewater Metabolic function Nitrogen metabolic pathway Extracellular polymeric substance